Fundz

Science&Humans raises $10 million in Series A funding led by Pender Ventures to accelerate its growth in hormone health services.

PRIVATEJan 15, 2026

Amount Raised

C$10 Million

Round Type

Series A

TorontoBiotechnologyHealth Care

Investors

Well Health TechnologiesMichele RomanowCIBC Innovation BankingPender Ventures

Description

Science&Humans has secured $10 million CAD in funding, including $7 million in equity and $3 million in venture debt as part of its Series A round. The Toronto-based healthtech company aims to expand its telemedicine platform that assists Canadians with hormone health management. This marks their first external financing beyond an initial $1 million credit from BDC. The funding will enable the company to capture a growing market interest in hormone health.

Quick answer

Science&Humans raised C$10 Million in a Series A round, dated January 15, 2026. Investors: Well Health Technologies, Michele Romanow, CIBC Innovation Banking and Pender Ventures. Science&Humans is based in Toronto, Ontario, Canada.

How much did Science&Humans raise?
Science&Humans raised C$10 Million in a Series A round on January 15, 2026.
Who invested in Science&Humans?
Well Health Technologies, Michele Romanow, CIBC Innovation Banking and Pender Ventures are named as investors in this round.
What does Science&Humans do?
Science&Humans is a Toronto-based healthtech company that offers a telemedicine platform to help Canadians manage their hormone health.
Where is Science&Humans based and how big is it?
Science&Humans is based in Toronto, Ontario, Canada. Fundz records about 76 employees.
Who are the decision-makers at Science&Humans?
Fundz holds 1 contact at Science&Humans. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Science&Humans that raised within 45 days of this round, from Fundz verified event records.

  • Biohaven raised $600M (Debt Financing) on March 1, 2026.
  • Salma Health raised $80M (Series A) on February 26, 2026.
  • Wholeleaf raised $165K (Seed) on February 26, 2026.
  • Blue Arbor Technologies raised $5M (Series A) on February 26, 2026.
  • Superbrewed Food raised an undisclosed amount (Corporate Round) on February 26, 2026.
  • BreezeBio raised $60M (Series B) on February 25, 2026.

Who to call at Science&Humans, and when

A new round usually means Science&Humans is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Science&Humans raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Science&Humans, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Science&Humans. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Science&Humans

Location

Toronto, Ontario, Canada

About

Science&Humans is a Toronto-based healthtech company that offers a telemedicine platform to help Canadians manage their hormone health. It provides personalized treatment for hormone health imbalances by connecting users with specialists who diagnose and treat issues such as low testosterone, menopause, and weight management. The company aims to address often-stigmatized health concerns through continuous care and prescription drugs. Leveraging a business-to-business model, it works with health insurers and large companies to deliver care to employees.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Science&Humans raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Science&Humans's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Science&Humans raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.